Benton B
Onchocerciasis Co-ordination Unit, World Bank, Washington, DC 20433, USA.
Ann Trop Med Parasitol. 1998 Apr;92 Suppl 1:S33-9. doi: 10.1080/00034989859537.
This note overviews several studies that have been conducted on the economic impact of onchocerciasis (river blindness) control through the African Programme for Onchocerciasis Control (APOC). A cost-benefit analysis of the APOC concludes that the programme is highly cost-effective. The economic rate of return (ERR) is 17% if benefits are considered in accordance with the stated objective of the programme (i.e. the achievement of long-term, sustainable, ivermectin-delivery systems). However, the cost-benefit analysis significantly under-estimates the net benefits from the APOC, since it considers, for ease of quantification, only the reduction in blindness as the principal benefit accruing from control activities. Recent studies, summarized here, have shown that there may be substantial benefits (in terms of enhanced productivity, increased household-level welfare, and reduced health-related expenditure, for instance) resulting from the reduction of the skin-related symptoms associated with the disease.
本报告概述了几项关于通过非洲盘尾丝虫病控制计划(APOC)开展的盘尾丝虫病(河盲症)控制工作对经济影响的研究。对APOC的成本效益分析得出结论,该计划具有很高的成本效益。如果按照该计划的既定目标(即实现长期、可持续的伊维菌素供应系统)来考虑效益,经济回报率(ERR)为17%。然而,成本效益分析严重低估了APOC的净效益,因为为便于量化,它仅将失明人数的减少视为控制活动产生的主要效益。此处总结的近期研究表明,减少与该疾病相关的皮肤症状可能会带来巨大益处(例如提高生产力、增加家庭层面的福利以及减少与健康相关的支出)。